BACKGROUND: Knowledge of acoustic neuroma (AN) growth is essential for treatment planning. METHODS: A retrospective analysis of 119 patients with AN (mean age, 65 years; range, 37-84 years) followed with interval magnetic resonance imagings (MRIs) was performed. Change in maximum tumor dimension as a function of follow-up period was analyzed. RESULTS: Overall, maximum tumor dimension increased >2 mm in only 30% of patients. Of those that grew, the mean growth rate was 3.8 mm/year (maximum, 25 mm/year). Age, gender, and laterality did not predict growth. Most tumors that grew (86.1 %) were <20 mm at presentation. However, tumors >20 mm were statistically more likely to grow (71%, p =0.028). CONCLUSIONS: Most ANs followed with periodic MRIs do not grow. Available clinical information usually cannot predict growth. Serial MRIs are advocated for all patients treated with observation.
BACKGROUND: Knowledge of acoustic neuroma (AN) growth is essential for treatment planning. METHODS: A retrospective analysis of 119 patients with AN (mean age, 65 years; range, 37-84 years) followed with interval magnetic resonance imagings (MRIs) was performed. Change in maximum tumor dimension as a function of follow-up period was analyzed. RESULTS: Overall, maximum tumor dimension increased >2 mm in only 30% of patients. Of those that grew, the mean growth rate was 3.8 mm/year (maximum, 25 mm/year). Age, gender, and laterality did not predict growth. Most tumors that grew (86.1 %) were <20 mm at presentation. However, tumors >20 mm were statistically more likely to grow (71%, p =0.028). CONCLUSIONS: Most ANs followed with periodic MRIs do not grow. Available clinical information usually cannot predict growth. Serial MRIs are advocated for all patients treated with observation.
Authors: Elizabeth A Vokurka; Amit Herwadkar; Neil A Thacker; Richard T Ramsden; Alan Jackson Journal: AJNR Am J Neuroradiol Date: 2002-03 Impact factor: 3.825
Authors: Benjamin J Arthurs; Wayne T Lamoreaux; Neil A Giddings; Robert K Fairbanks; Alexander R Mackay; John J Demakas; Barton S Cooke; Christopher M Lee Journal: World J Surg Oncol Date: 2009-12-18 Impact factor: 2.754
Authors: Jacob B Hunter; David O Francis; Brendan P O'Connell; Edmond K Kabagambe; Marc L Bennett; George B Wanna; Alejandro Rivas; Reid C Thompson; David S Haynes Journal: Otol Neurotol Date: 2016-12 Impact factor: 2.311
Authors: Janneke C J M Artz; Ferdinand C A Timmer; Jef J S Mulder; Cor W R J Cremers; Kees Graamans Journal: Eur Arch Otorhinolaryngol Date: 2008-08-13 Impact factor: 2.503
Authors: Romain Kania; Benjamin Vérillaud; Domitille Camous; Charlotte Hautefort; Thomas Somers; Jérôme Waterval; Sébastien Froelich; Philippe Herman Journal: J Int Adv Otol Date: 2018-04 Impact factor: 1.017
Authors: Rick van de Langenberg; Bert Jan de Bondt; Patty J Nelemans; Brigitta G Baumert; Robert J Stokroos Journal: Neuroradiology Date: 2009-05-06 Impact factor: 2.804